Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.23 new

Vol. 6, Issue 8 (2017)

Quality of life parameters of patients with combined pathology of asthma and COPD on baseline therapy

Author(s):
Feschenko YI and Nazarenko KV
Abstract:

The current prevalence of obstructive lung diseases (COPD and asthma) remains high in Ukraine and in the world. These diseases alone and in combination are a significant medical and social problem of humanity. The aim of our study was to evaluate the quality of life of patients with combined pathology of asthma and COPD, as well as compare it with such of patients with asthma and COPD. In patients with asthma, COPD and their combination significant violations of all components of quality of life were revealed (according to the SGRQ). Activity limitation was more pronounced in COPD and asthma +COPD compared with asthma. In patients with combined pathology, quality of life worsens with an increase in the degree of bronchial obstruction and with increased respiratory resistance. The considerable smoking history (more than 10 pack-years) also affects all components of the quality of life.
Pages: 12-16  |  1275 Views  10 Downloads


The Pharma Innovation Journal
How to cite this article:
Feschenko YI, Nazarenko KV. Quality of life parameters of patients with combined pathology of asthma and COPD on baseline therapy. Pharma Innovation 2017;6(8):12-16.
Important Publications Links
The Pharma Innovation Journal

The Pharma Innovation Journal

Call for book chapter
The Pharma Innovation Journal